Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain

Neuroscience

Volumn 87, Issue 2, 1998, Pages 319-324

  Pasinetti, G M ^a   Aisen, P S ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY RNA; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT;

ALZHEIMER DISEASE; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; ENZYME INHIBITION; ENZYME REGULATION; FRONTAL CORTEX; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALZHEIMER DISEASE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CYCLOOXYGENASE 2; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES; MEMBRANE PROTEINS; NEURONS; PREFRONTAL CORTEX; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER;

EID: 0032551633     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00218-8     Document Type: Article

References (22)

1. Adams J., Collaço-Moraes Y., de Belleroche J. Cyclooxygenase-2 induction in cerebral cortex: an intracellular response to synaptic excitation. J. Neurochem. 66:1996;6-13.
2. Aisen P. S., Davis K. L. Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am. J. Psychiat. 151:1994;1105-1113.
3. Bruce A. J., Malfroy B., Baudry M. β-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc. natn. Acad. Sci. U.S.A. 93:1996;2312-2316.
4. Cao C., Matsumura K., Yamagata K., Watanabe Y. Induction by lipopolysaccharide of cyclooxygenase-2 mRNA in rat brain; its possible role in the febrile response. Brain Res. 697:1995;187-196.
5. Chan P. H., Fishman R. A. Transient formation of superoxide radicals in polyunsaturated fatty acid-induced brain swelling. J. Neurochem. 35:1980;1004-1007.
6. Chang J. W., Coleman P. D., O'Banion M. K. Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimer's disease. Neurobiol. Aging. 17:1996;801-808.
7. Diaz A., Reginato A. M., Jimenez S. A. Alternative splicing of human prostaglandin G/H synthase mRNA and evidence of differential regulation of the resulting transcripts by transforming growth factor 1β, and tumor necrosis factor α J. biol. Chem. 267:1992;10816-10822.
8. Kaufmann W. E., Worley P. F., Pegg J., Bremer M., Isakson P. COX-2, a synaptically induced enzyme, is expressed by excitatory neurons at postsynaptic sites in rat cerebral cortex. Proc. natn. Acad. Sci. U.S.A. 93:1996;2317-2321.
9. Khachaturian Z. S. Diagnosis of Alzheimer's disease. Archs Neurol. 42:1985;1097-1105.
10. Kujubu D. A., Fletcher B. S., Varnum B. C., Lim R. W., Herschman H. R. TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. biol. Chem. 266:1991;12866-12872.
11. Lampert-Etchells M., Pasinetti G. M., Finch C. E., Johnson S. A. Regional localization of cells containing complement C1q and C4 mRNAs in the frontal cortex during Alzheimer's disease. Neurodegeneration. 2:1993;111-121.
12. Lukiw W. J., Bazan N. G. Cyclooxygenase 2 RNA message abundance, stability, and hypervariablility in sporadic Alzheimer neocortex. J. Neurosci. Res. 50:1997;937-945.
13. McGeer P. L., Schulzer M., McGeer E. G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology. 47:1996;425-432.
14. Mirra S. S. The CERAD neuropathology protocol and consensus recommendations for the postmortem diagnosis of Alzheimer's disease: a commentary. Neurobiol. Aging. 18:1997;S91-S94.
15. O'Banion M. K., Winn V. D., Young D. A. cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase. Proc. natn. Acad. Sci. U.S.A. 89:1992;4888-4892.
16. Oda T., Lehrer-Graiwer J., Finch C. E., Pasinetti G. M. Complement and β-amyloid (aβ) neurotoxicity in vitro: a model for Alzheimer disease. Alzheimer's Res. 1:1995;29-34.
17. Oka A., Takashima S. Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons. NeuroReport. 8:1997;1161-1164.
18. Pasinetti G. M. Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system. Neurobiol. Aging. 17:1996;707-716.
19. Richardson J. S. Free radicals in the genesis of Alzheimer's disease. Ann. N. Y. Acad. Sci. 695:1993;73-76.
20. Shearman M. S., Ragan C. I., Iversen L. L. Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc. natn. Acad. Sci. U.S.A. 91:1994;1470-1474.
21. Tocco G., Freire O., Schreiber S. S., Sakhi S. H., Aisen P. S., Pasinetti G. M. Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease. Expl Neurol. 144:1997;339-349.
22. Yamagata K., Andreasson K. I., Kaufmann W. E., Barnes C. A., Worley P. F. Expression of a mitogen-inducible cyclooxygenase in brain neurons: regulation by synaptic activity and glucocorticoids. Neuron. 11:1993;371-386.